The Enterprise Value as of November 2025 (TTM) for Obalon Therapeutics, Inc. (OBLN) is -196093.00

According to Obalon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -196093.00. This represents a change of -81.73% compared to the average of -1073084.44 of the last 4 quarters.

Obalon Therapeutics, Inc. (OBLN) Historical Enterprise Value (quarterly & annually)

How has OBLN Enterprise Value performed in the past?

The mean historical Enterprise Value of Obalon Therapeutics, Inc. over the last ten years is 63.30M. The current -196093.00 Enterprise Value has changed -130.98% with respect to the historical average. Over the past ten years (40 quarters), OBLN's Enterprise Value was at its highest in in the September 2016 quarter at 246.86M. The Enterprise Value was at its lowest in in the June 2021 quarter at -10694064.95.

Obalon Therapeutics, Inc. (OBLN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Obalon Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Obalon Therapeutics, Inc. (OBLN) Average Enterprise Value

How has OBLN Enterprise Value performed in the past?

The current Enterprise Value of Obalon Therapeutics, Inc. (OBLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Obalon Therapeutics, Inc. (OBLN) Enterprise Value vs. Peers

How is OBLN’s Enterprise Value compared to its peers?

Obalon Therapeutics, Inc.’s Enterprise Value is less than Holdco Nuvo Group D.G Ltd. Ordinary Shares (17.10M), less than Regional Health Properties, Inc. (1.99M), less than Greenbrook TMS Inc. (111.43M), less than Invitae Corporation (1.50B), greater than ViewRay, Inc. (-44998227.00), less than Xylo Technologies Ltd. (1.88M), less than UpHealth, Inc. (147.26M), greater than Fresh Tracks Therapeutics, Inc. (-5282955.00), less than Regional Health Properties, Inc. (1.99M), less than LumiraDx Limited (306.34M),

Build a custom stock screener for Obalon Therapeutics, Inc. (OBLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Obalon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Obalon Therapeutics, Inc. (OBLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Obalon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.